(Q48712285)

14 February 2018

title

Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex. (English)

1 reference

14 February 2018

author name string

Pehek EA

series ordinal

1

1 reference

14 February 2018

Bi Y

series ordinal

2

1 reference

14 February 2018

publication date

1 May 1997

1 reference

14 February 2018

Progress in Neuro-Psychopharmacology & Biological Psychiatry

published in

1 reference

14 February 2018

volume

21

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

page(s)

671-682

1 reference

14 February 2018

Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

5-hydroxytryptamine stimulates [3H]dopamine release from the fish retina

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Evidence for carrier-mediated efflux of dopamine from corpus striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Effect of cocaine and 5-HT3 receptor antagonists on 5-HT=indeced [5H]dopamine release from rat striatal synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900040-7

7 January 2021

10.1016/S0278-5846(97)00040-7

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9194148

1 reference

14 February 2018